26 May 2013
Keywords: acelrx, oral, sufentanilin, shows, strong, ph, ii
Article | 15 December 2008
AcelRx Pharmaceuticals, a privately-held US pharmaceutical company dedicated to the development and commercialization of new therapies for
the treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 December 2008
24 May 2013
© 2013 thepharmaletter.com